Skip to main content
. 2014 Mar 3;20:200–214.

Table 2. Clinical and biochemical markers for the studied groups.

Clinical characteristics DWR (n=284) DR (n=216) p value
Age of diabetic onset (years)
52.7±7.61
50.67±9.41
0.008
Sex (Male/Female)
111/173
103/113
0.054
Duration of diabetes (years)
14.79±4.97
13.44±7.22
0.013
BMI (kg/m2)
25.26±3.95
25.8±4.13
0.14
WHR
0.92±0.06
0.93±0.06
0.5
High albuminuria(-/+)
240/38
143/68
<0.001
Systolic blood pressure (mmHg)
136.7±16.65
138.5±17.18
0.22
Diastolic blood pressure (mmHg)
77.65±9.36
79.23±9.69
0.066
Insulin therapy (yes/no)
92/191
118/97
<0.001
HbA1c (%)
6.97±1.40
7.84±1.70
<0.001
FPG (mmol/l)
8.09±2.43
9.22±3.21
<0.001
Creatinine (µmol/l)
67.43±17.69
73.66±49.84
0.027
Uric acid (µmol/l)
281.9±82.42
281.1±76.58
0.98
Cholesterol (mmol/l)
5.05±0.98
5.18±1.17
0.19
Triglycerides (mmol/l)
1.55±0.93
1.73±1.52
0.11
HDL cholesterol (mmol/l)
1.25±0.30
1.23±0.30
0.38
LDL cholesterol (mmol/l) 3.07±0.83 3.08±0.90 0.83

The data are expressed as mean ± standard deviation (SD) or number of subjects. Differences between diabetic retinopathy (DR) and diabetic without retinopathy (DWR) groups were compared using t test or Chi-square test. BMI, body mass index; WHR, waist and hip ratio; HbA1c, glycosylated hemoglobin A1c; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein.